Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

210.00
Delayed Data
As of 4:01pm ET
 -5.00 / -2.33%
Today’s Change
184.50
Today|||52-Week Range
256.80
-0.00%
Year-to-Date
Adding to Some Longs
1:38pm / TheStreet.com - Paid Partner Content
Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round
Sep 19 / TheStreet.com - Paid Partner Content
Citigroup Still Loves Allergan
9:09am / TheStreet.com - Paid Partner Content
Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Morgan Stanley Downgrades Allergan
7:06am / TheStreet.com - Paid Partner Content
How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)
Sep 19 / TheStreet.com - Paid Partner Content
Centene: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
Going Large on Allergan
Sep 19 / TheStreet.com - Paid Partner Content
The Pitney Bowes Transformation: Cramer's Top Takeaways
Sep 19 / TheStreet.com - Paid Partner Content
My Takeaways and Observations (Early Afternoon Edition)
Sep 19 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close215.00
Today’s open211.74
Day’s range208.90 - 214.12
Volume5,474,225
Average volume (3 months)2,162,726
Market cap$71.9B
Dividend yield1.33%
Data as of 4:01pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.05%
Earnings growth (next 5 years)+15.23%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.26+0.80%
ABTAbbott Laboratories+0.48+0.93%
LLYEli Lilly and Co+0.29+0.35%
NVONovo Nordisk+0.46+0.95%
Data as of 4:02pm ET, 09/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.17
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts